Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases
Mast cells have crucial roles in allergic and other inflammatory diseases. Preclinical
approaches provide circumstantial evidence for mast cell involvement in many diseases, but …
approaches provide circumstantial evidence for mast cell involvement in many diseases, but …
Anti‐IL‐5 therapies for asthma
Antecedentes Esta la segunda actualización de una revisión publicada anteriormente en la
Biblioteca Cochrane (2015, primera actualización en 2017). La interleucina 5 (IL‐5) es la …
Biblioteca Cochrane (2015, primera actualización en 2017). La interleucina 5 (IL‐5) es la …
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Over the past two decades, significant progress in understanding of the pathogenesis of type
2 chronic inflammatory diseases has enabled the identification of compounds for more than …
2 chronic inflammatory diseases has enabled the identification of compounds for more than …
The pathogenesis of chronic spontaneous urticaria: the role of infiltrating cells
AM Giménez-Arnau, L de Montjoye, R Asero… - The Journal of Allergy …, 2021 - Elsevier
Chronic spontaneous urticaria is characterized by a perivascular non-necrotizing cellular
infiltrate around small venules of the skin. It consists primarily of CD4 (+) lymphocytes, a …
infiltrate around small venules of the skin. It consists primarily of CD4 (+) lymphocytes, a …
Eosinophil knockout humans: uncovering the role of eosinophils through eosinophil-directed biological therapies
The enigmatic eosinophil has emerged as an exciting component of the immune system,
involved in a plethora of homeostatic and inflammatory responses. Substantial progress has …
involved in a plethora of homeostatic and inflammatory responses. Substantial progress has …
[HTML][HTML] An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria
S Altrichter, P Staubach, M Pasha, B Singh… - Journal of Allergy and …, 2022 - Elsevier
Background Chronic urticaria (CU) is a debilitating mast cell–driven disease, often refractory
to standard therapy (ie, antihistamines). Lirentelimab, an anti–sialic acid–binding …
to standard therapy (ie, antihistamines). Lirentelimab, an anti–sialic acid–binding …
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
KL Kliewer, C Murray-Petzold, MH Collins… - The Lancet …, 2023 - thelancet.com
Background In eosinophilic gastrointestinal diseases, the role of eosinophils in disease
pathogenesis and the effect of eosinophil depletion on patient outcomes are unclear …
pathogenesis and the effect of eosinophil depletion on patient outcomes are unclear …
Chronic urticaria: advances in understanding of the disease and clinical management
L He, W Yi, X Huang, H Long, Q Lu - Clinical reviews in allergy & …, 2021 - Springer
Chronic urticaria (CU) is a common skin condition characterized by the recurrence of
wheals, with or without angioedema, which lasts for at least 6 weeks. Owing to its pruritus …
wheals, with or without angioedema, which lasts for at least 6 weeks. Owing to its pruritus …
Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment
Chronic urticaria is a common and debilitating mast cell-driven skin disease presenting with
itchy wheals, angio-oedema, or both. Chronic urticaria is classified as spontaneous (without …
itchy wheals, angio-oedema, or both. Chronic urticaria is classified as spontaneous (without …